Serum methionine metabolites are risk factors for metastatic prostate cancer progression.
Stabler S, Koyama T, Zhao Z, Martinez-Ferrer M, Allen RH, Luka Z, Loukachevitch LV, Clark PE, Wagner C, Bhowmick NA.
Stabler S, et al. Among authors: loukachevitch lv.
PLoS One. 2011;6(8):e22486. doi: 10.1371/journal.pone.0022486. Epub 2011 Aug 10.
PLoS One. 2011.
PMID: 21853037
Free PMC article.